NeoGenomics, Inc. (NEO) compared with its closest peers (ULS, CAI, MYGN, NEOG, LMRI). Peer set by Business Services; 10 comparable business services companies. First-party data.
UL Solutions shares NeoGenomics's sub-industry, testing laboratories.
| Company | Market Cap | P/E |
|---|---|---|
| UL Solutions Inc. (ULS) | $14.88B | 29.5 |
| Caris Life Sciences, Inc. (CAI) | $7.01B | 66.6 |
| Myriad Genetics, Inc. (MYGN) | $309.90M | -1.6 |
| Neogen Corporation (NEOG) | $2.57B | -224.1 |
| Lumexa Imaging Holdings, Inc. Common Stock (LMRI) | $1.13B | 656.4 |
| Guardant Health, Inc. (GH) | $21.88B | -30.8 |
| Veracyte, Inc. (VCYT) | $3.59B | 31.3 |
| Sotera Health Company (SHC) | $5.41B | 33.1 |
| CareDx, Inc (CDNA) | $2.57B | 23.1 |
| Castle Biosciences, Inc. (CSTL) | $1.02B | -46.9 |
| Sector P/E (Technology) | 31.8 |
| Industry P/E (Business Services) | 28.3 |
NEO overview · NEO earnings · NEO financials · NEO KPIs · NEO documents · NEO ownership
Data sourced from U.S. SEC EDGAR filings and market data. Not personalized investment advice.